Brief: Invivyd Announces Continued Neutralizing Activity Of Pemgarda And VYD2311 Against Currently Dominant Sars-Cov-2 Variant XFG
18/08/2025 21:39
Aug 18 (Reuters) - Invivyd Inc IVVD.O: INVIVYD ANNOUNCES CONTINUED NEUTRALIZING ACTIVITY OF PEMGARDA® (PEMIVIBART) AND VYD2311 AGAINST CURRENTLY DOMINANT SARS-COV-2 VARIANT XFG (“STRATUS”) Source text: ID:nGNX4nyjtv Further company coverage: IVVD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invivyd
See all newsBrief: Invivyd Announces Positive Topline Results From Liberty Phase 3 Study Demonstrating Vyd2311 Safety And Tolerability Superior To Mrna-Based Covid-19 Vaccine Announces Regulatory Submission Plans For Vyd2311
Invivyd, Inc. reports results for the quarter ended June 30 - Earnings Summary
Invivyd Q2 loss per share comes wider than expected on higher costs
Brief: Invivyd Q2 EPS USD -0.14
Invivyd, Inc. expected to post a loss of 11 cents a share - Earnings Preview